Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6361-6369

  Amado, Rafael G ^a   Jamieson, Beth D ^a   Cortado, Ruth ^a   Cole, Steve W ^a   Zack, Jerome A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; INDINAVIR; VIRUS ANTIGEN; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOREACTIVITY; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFECTION; REPORTER GENE; THYMOCYTE; THYMUS FUNCTION; THYMUS GRAFT;

EID: 0032786466     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6361-6369.1999     Document Type: Article

References (39)

1. Aldrovandi, G. M., G. Feuer, L. Gao, B. Jamie son, M. Kristeva, I. S. Y. Chen, and J. A. Zack. 1993. HIV-I infection of the SCID-hu mouse: an animal model for virus pathogenesis. Nature 363:732-736.
2. Amado, R G., G. Symonds, B. D. Jamieson, G. Zhao, J. D. Rosenblatt, and J, A. Zack. 1998. Effects of megakaryocyte growth and development factor on survival and retroviral transduction of T lymphoid progenitor cells. Hum. Gene Ther. 9:173-183.
3. Angel, J. B., A. Kumar, K. Parato, L. G. Filion, F. Diaz-Mitoma, P. Daftarian, B. Pham, E. Sun, J. M. Leonard, and D. W. Cameron. 1998. Improvement in cell-mediated immune function during potent anti-human immuno-deficiency virus therapy with ritonavir plus saquinavir. J. Infect. Dis. 177: 898-904.
4. + T cell homeostasis and function in advanced HIV disease. Science 277:112-116.
5. Bertho, J. M., C. Demarquay, N. Moulian, A. Van Der Meeren, S. Berrih-Aknin, and P. Gourmelon. 1997. Phenotypic and immunohistological analyses of the human adult thymus: evidence for an active thymus during adult life. Cell Immunol. 179:30-40.
6. Bonyhadi, M. L., L. Rabin, S. Salimi, D. A. Brown, J. Kosek, J. M. McCune, and H. Kaneshima. 1993. HIV induces thymus depletion in vivo. Nature 363:728-732.
7. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530.
8. Chun, T. W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV-I latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193-13197.
9. Douek, D. C., R. D. McFarland, P. H. Keiser, E. A. Gage, J. M. Massey, B. F. Haynes, M. A. Polis, A. T. Haase, M. B. Feinberg, J. L. Sullivan, B. D. Jamieson, J. A. Zack, L. J. Picker, and R. A. Koup. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695.
10. Finzi, D., M. Hermankova, T. Pierson. L. M. Carruth, C. Buck, R. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-I in patients on highly active antiretroviral therapy. Science 278:1295-1300.
11. Havlir, D., and D. Richman. Personal communication.
12. Heitger, A., N. Neu, H. Kern, E. R. Panzer-Grümayer, H. Greinix, D. Nachbaur, D. Niederwieser, and F. M. Fink. 1997. Essential role of the thymus to reconstitute naïve (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. Blood 90:850-857.
13. Hirsch, M. S., B. Conway, R. T. D'Aquila, V. A. Johnson, F. Brun-Vézinet, B. Clotet, L. M. Demeter, S. M. Hammer, D. M. Jacobsen, D. R. Kuritzkes, C. Loveday, J. W. Mellors, S. Vella, and D. D. Richman. 1998. Antiretroviral drug resistance testing in adults with HIV infection: implication for clinical management. International AIDS Society - USA Panel. JAMA 279:1984-1991.
14. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-I infection. Nature 373:123-126.
15. Jamieson, B. D., G. M. Aldrovandi, V. Planelles, J. B. Jowett, L. Gao, L. M. Bloch, I. S. Y. Chen, and J. A. Zack. 1994. Requirement of HIV-I nef for in vivo replication and pathogenesis. J. Virol. 68:3478-3485.
16. Jamieson, B. D., and J. A. Zack. 1998. In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus. J. Virol. 72:6520-6526.
17. Kitchen, S. G., and J. A. Zack. 1997. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J. Virol. 71:6928-6934.
18. Koka, P. S., J. K. Fraser, Y. Bryson, G. C. Bristol, G. M. Aldrovandi, E. S. Daar, and J. A. Zack. 1998. Human immunodeficiency virus inhibits multi-lineage hematopoiesis in vivo. J. Virol. 72:5121-5127.
19. Kort, J. J., J. A. Bilello, G. Bauer, and G. L. Drusano. 1993. Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrob. Agents Chemother. 37:115-119.
20. Kourtis, A. P., C. Ibegbu, A. J. Nahmias, F. K. Lee, W. S. Clark, M. K. Sawyer, and S. Nesheim. 1996. Early progression of disease in HIV-infected infants with thymus dysfunction. N. Engl. J. Med. 335:1431-1436.
21. Lafeuillade, A., L. Chollet, G. Hittinger, N. Profizi, O. Costes, and C. Poggi. 1998. Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies/mL. J. Infect. Dis. 177:235-238.
22. Lederman, M. M., E. Connick, A. Landay, D. R. Kuritzkes, J. Spritzler, M. St. Clair, B. L. Kotzin, L. Fox, M. H. Chiozzi, J. M. Leonard, F. Rousseau, M. Wade, J. D. Roe, A. Martinez, and H. Kessler. 1998. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J. Infect. Dis. 178:70-79.
23. Mackall, C. L., T. A. Fleisher, M. R. Brown, M. P. Andrich, C. C Chen, I. M. Feuerstein, M. E. Horowitz, I. T. Magrath, A. T. Shad, S. M. Steinberg, L. H. Wexler, and R. E. Gress. 1995. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 332:143-149.
24. McCune, J. M., R. Loftus, D. K. Schmidt, P. Carroll. D. Webster, L. B. Swor-Yim, I. R. Francis, B. H. Gross, and R. M. Grant. 1998. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J. Clin. Investig. 101:2301-2308.
25. McCune, J. M., R. Namikawa, H. Kaneshima, L. D. Shultz, M. Lieberman, and I. L. Weissman. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639.
26. Namikawa, R., H. Kaneshima, M. Lieberman, I. L. Weissman, and J. M. McCune. 1988. Infection of SCID-hu mouse by HIV-I. Science 242:1684-1686.
27. Namikawa, R., K. N. Weilbaecher, H. Kaneshima, E. J. Yee, and J. M. McCune. 1990. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172:1055-1063.
28. Pakker, N. G., D. W. Notermans, R. J. de Boer, M. T. Roos, F. de Wolf, A. Hill, J. M. Leonard, S. A. Danner, F. Miedema, and P. T. Schellekens. 1998. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-I infection: a composite of redistribution and proliferation. Nat. Med. 4:208-214.
29. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-I-infected compartments during combination therapy. Nature 387:188-191.
30. Perelson, A. S., P. Essunger, and D. D. Ho. 1997. Dynamics of HIV-I and CD4+ lymphocytes in vivo. AIDS II(Suppl. A):S17-S24.
31. Pettoello-Mantovani, M., T. R. Kollmann, C. Raker, A. Kim, S. Yurasov, R. Tudor, H. Wiltshire, and H. Goldstein. 1997. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues. Antimicrob. Agents Chemother. 41:1880-1887.
32. Rosenzweig, M., D. P. Clark, and G. N. Gaulton. 1993. Selective thymocyte depletion in neonatal HIV-I thymic infection. AIDS 7:1601-1605.
33. Simpson, J. G., E. S. Gray, and J. S. Beck. 1975. Age involution in the normal human adult thymus. Clin. Exp. Immunol. 19:261-265.
34. Sprent, P. 1989, Applied nonparametric statistical methods. Chapman and Hall, New York, N.Y.
35. von Gaudecker, B. 1978. Ultrasound of the age-involuted adult human thymus. Cell Tissue Res. 184:507-525.
36. Wainberg, M. A., and G. Friedland. 1998. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 279:1977-1983.
37. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E, A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
38. Withers-Ward, E. S., R. G. Amado, P. S. Koka, B. D. Jamieson, A. H. Kaplan, I. S. Y. Chen, and J. A. Zack. 1997. Transient renewal of thymopoiesis in HIV infected human thymic implants following antiviral therapy. Nat. Med. 3:1102-1109.
39. Wong, J. K., M. Hezareh, H. F. Günthard, D. V. Havlir, C. C Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.